Insider selling at this scale is too small to warrant a directional trade. Aiyar and Formela are significant shareholders; a single modest open-market sale by each is within normal liquidity patterns. Traders should focus on upcoming pipeline catalysts (phase data, trial updates) rather than this insider activity.
Price Chart
Executive Summary
Two insiders at Korro Bio, CEO Ram Aiyar and Director Jean Francois Formela, sold a combined $231K in open-market sales over two days. The CEO’s $197K sale represents roughly 0.1% of the $186M market cap, a modest amount that is routine relative to company size. No other material corporate events or filings accompany these sales, suggesting liquidity-driven or pre-scheduled dispositions rather than a bearish signal.
Key Financial Metrics
Key Facts
- CEO Ram Aiyar sold 15,152 open-market shares on 2026-05-29 for ~$197K.
- Director Jean Francois Formela sold 2,441 open-market shares on 2026-05-28 for ~$34K.
- Combined $231K in sales equals ~0.12% of Korro Bio's $186M market cap.
- No 10b5-1 plan designation is stated in the filings, but the modest dollar amounts and single-transaction-per-insider pattern are consistent with routine portfolio rebalancing or tax management.
- No recent earnings, M&A, or regulatory catalyst was filed alongside this cluster.
- The analyst consensus is heavily bullish (81% buy), contrasting with the insider activity.
Financial Impact
Total insider selling of $231K represents ~0.12% of market cap.
Risk Factors
- If additional unannounced insider selling follows, the pattern could shift from routine to concerning.
- No earnings or material event in the window; the lack of context makes these trades less informative.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KRRO-1780398034986 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $12.73 | awaiting T+1 | — | $13.30 (+4.48%) |
Oct 26, 2026 1d ago | Insider Buy | $12.46 | awaiting T+1 | — | $13.30 (+6.74%) |
Oct 22, 2026 5d ago | 8-K | $12.05 $11.98 | ▼ −0.58% | ▼ −0.06% | $13.30 (+10.37%) |
Oct 16, 2026 11d ago | Press Release | $8.91 $9.44 | ▲ +5.95% | ▲ +5.61% | $13.30 (+49.27%) |
Oct 5, 2026 22d ago | 8-K | $9.76 $10.49 | ▲ +7.48% | ▲ +7.72% | $13.30 (+36.27%) |
Oct 5, 2026 22d ago | Press Release | $9.76 $10.49 | ▲ +7.48% | ▲ +7.72% | $13.30 (+36.27%) |
Sep 15, 2026 6w ago | Insider Cluster | $13.83 $11.80 | ▼ −14.68% | ▼ −15.81% | $13.30 (−3.83%) |
Aug 13, 2026 10w ago | Insider Cluster | $13.29 $13.28 | ▼ −0.08% | ▲ +0.12% | $13.30 (+0.08%) |
Aug 6, 2026 11w ago | 8-K | $12.12 $13.25 | ▲ +9.32% | ▲ +8.71% | $13.30 (+9.74%) |
Jul 9, 2026 15w ago | Institutional Cluster | $14.30 $14.56 | ▲ +1.82% | ▲ +1.39% | $13.30 (−6.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers